Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My case for MO MONEY, a novelette

Maybe RG knows somthing we don't and feels the low SP is very temporary. In his letter he said the M&A evaluation process takes time. It may be a while (late summer perhaps) before they pull the trigger on a deal. A lot will or may happen between now and then ie. USPTO, 10-K, T3. The SP situation may turn around soon.

All the best,

Steve

Share
New Message
Please login to post a reply